As tensions with Tehran escalate, Alma Center pundits urge drying up the supply of weapons to Shiite terror group; warn that ...
AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...
On Friday, Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.7 which represents a slight increase of $0.07 or 4.29% from the prior close of $1.63. The stock opened at $1.63 and touched ...
Cerus (NASDAQ:CERS – Free Report) had its target price trimmed by Stifel Nicolaus from $6.00 to $3.00 in a report issued on Thursday morning, MarketBeat.com reports. The brokerage currently has a buy ...
In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Cerus (CERS – Research Report). The ...
On Monday, Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.72 which represents a slight increase of $0.02 or 1.18% from the prior close of $1.7. The stock opened at $1.68 and touched ...
Nurix Therapeutics’ BTK degrader has elicited responses in a small group of patients with certain cancers, supporting the ...
Cerus Corp (CERS) reports a 16% increase in product revenue and raises full-year guidance, despite challenges in government contracts and EU regulatory delays. The insider now owns 536,093 shares ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...